Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for Neogen (NEOG) over the last 4 years, with Q2 2025 value amounting to $374000.0.

  • Neogen's Gains from Sales and Divestitures rose 6260.87% to $374000.0 in Q2 2025 from the same period last year, while for May 2025 it was $374000.0, marking a year-over-year increase of 6260.87%. This contributed to the annual value of $374000.0 for FY2025, which is 6260.87% up from last year.
  • Latest data reveals that Neogen reported Gains from Sales and Divestitures of $374000.0 as of Q2 2025, which was up 6260.87% from $230000.0 recorded in Q2 2024.
  • Neogen's 5-year Gains from Sales and Divestitures high stood at $374000.0 for Q2 2025, and its period low was $25000.0 during Q2 2022.
  • For the 4-year period, Neogen's Gains from Sales and Divestitures averaged around $172250.0, with its median value being $145000.0 (2023).
  • In the last 5 years, Neogen's Gains from Sales and Divestitures soared by 28333.33% in 2024 and then skyrocketed by 6260.87% in 2025.
  • Neogen's Gains from Sales and Divestitures (Quarter) stood at $25000.0 in 2022, then soared by 140.0% to $60000.0 in 2023, then surged by 283.33% to $230000.0 in 2024, then skyrocketed by 62.61% to $374000.0 in 2025.
  • Its Gains from Sales and Divestitures was $374000.0 in Q2 2025, compared to $230000.0 in Q2 2024 and $60000.0 in Q2 2023.